[Symptomatic primary human immunodeficiency virus infection]. 1997

C Bachmeyer, and G Grateau, and D Sereni
Département de médecine interne, hôpital Laënnec, Creil, France.

Symptomatic primary human immunodeficiency virus (HIV) infection was originally defined as a mononucleosis-like syndrome, with or without lymphocytic meningitis, associated with seroconversion for HIV. However, other protean clinical manifestations have been reported, and diagnosis should be considered in patients with risk factors for HIV who experience acute infectious illness, requiring search for p24 antigenemia and development of HIV antibodies. The clinical presentation of symptomatic HIV infection could predict the subsequent disease progression. In several studies, it is associated with poor prognosis. Pathogenesis relies on the host immune response and on virologic parameters. Early antiretroviral therapy on acute HIV infection could modify the course of infection.

UI MeSH Term Description Entries
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

C Bachmeyer, and G Grateau, and D Sereni
September 1989, The Pediatric infectious disease journal,
C Bachmeyer, and G Grateau, and D Sereni
November 2002, Infection control and hospital epidemiology,
C Bachmeyer, and G Grateau, and D Sereni
January 1990, Annales de dermatologie et de venereologie,
C Bachmeyer, and G Grateau, and D Sereni
April 1991, Clinical science (London, England : 1979),
C Bachmeyer, and G Grateau, and D Sereni
October 1990, Annals of internal medicine,
C Bachmeyer, and G Grateau, and D Sereni
January 1989, The Journal of infection,
C Bachmeyer, and G Grateau, and D Sereni
January 1991, The New England journal of medicine,
C Bachmeyer, and G Grateau, and D Sereni
January 2023, Indian journal of sexually transmitted diseases and AIDS,
C Bachmeyer, and G Grateau, and D Sereni
July 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
C Bachmeyer, and G Grateau, and D Sereni
June 2005, Current HIV/AIDS reports,
Copied contents to your clipboard!